Task C19: Efficacy of amoxicillin and amoxicillin/clavulanate in NHP model of anthrax

任务 C19：阿莫西林和阿莫西林/克拉维酸在 NHP 炭疽模型中的功效

• 批准号: 9430036
• 负责人: MILES CARROLL
• 金额: $ 0.03万
• 依托单位: UK HEALTH SECURITY AGENCY
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-10-31 至 2017-10-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9430036
• 关键词: Amoxicillin; Anthrax disease; Bacillus anthracis; Clavulanate; Contracts; Development; Licensure; Modeling; Standardization; Therapeutic; animal model development; efficacy testing; infectious disease model; nonhuman primate

This contract provides for the development and standardization of non-human primate models for infectious diseases, and may include efficacy testing of candidate products, including GLP studies to support licensure.

该合同规定了传染病非人灵长类动物模型的开发和标准化，并可能包括候选产品的功效测试，包括支持许可的GLP研究。